Efficacy of vagus nerve stimulation in 95 children of drug-resistant epilepsy with structural etiology
Epilepsy & Behavior · 2023
DOI: 10.1016/j.yebeh.2023.109107 ↗Kurz gefasst
Fachartikel in der Zeitschrift Epilepsy & Behavior, 2023. Verfasst von Han Xie und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Peking University First Hospital, Beijing, China; Pediatric Epilepsy Center, Peking University First Hospital, Beijing, Chi…. Hauptthemen laut MEDLINE: Vagus Nerve Stimulation, Epilepsy, Drug Resistant Epilepsy. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 23 Literaturangaben. Gefördert von: National Key Research and Development Program of China.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Vagus nerve stimulation (VNS) is one of the treatment options for drug-resistant epilepsy (DRE). To analyze the efficacy of VNS in children of DRE with structural etiology, we conducted a cohort study including 95 patients of DRE with structural etiology who underwent VNS treatment. Patients were followed up every 3 months at the outpatient department or via a remote programming platform. The median follow-up period was 2.6 years (range 1.0-4.6 years). The respective responder rates at 6, 12, 18, and 24 months of follow-up were 40.0% (38/95), 52.6% (50/95), 56.0% (47/84), and 59.7% (37/62). The respective seizure-free rates at 12, 18, and 24 months of follow-up were 8.4% (8/95), 9.5% (8/84), and 9.7% (6/62). The patients were divided into four groups based on etiologies: malformations of cortical development (n = 26), post-encephalitic lesions (n = 36), perinatal brain injury lesions (n = 31), and hippocampal sclerosis (n = 2). The respective responder rates at 12 months of follow-up in these groups were 53.8% (14/26), 52.8% (19/36), 51.6% (16/31), and 50.0% (1/2). There were no significant differences in gender, age at onset, age at stimulator implantation, epilepsy duration prior to VNS implantation, number of anti-seizure medications ever tried before VNS treatment, pulse amplitude of VNS, specific structural etiologies, lobe distribution or hemispheric side of structural lesions between responders and non-responders. Of the 95 patients, 8 (8.4%) underwent lesion surgery or hemispherectomy before VNS implantation, and 6/8 (75%) of these patients had a >50% reduction in seizure frequency. One patient who had a corpus callosotomy before VNS implantation had no response to VNS treatment. In conclusion, VNS is an effective treatment in children of DRE with structural etiology. There was no significant difference in VNS efficacy in patients with different structural etiologies. Vagus nerve stimulation treatment may also control seizures well in some patients with poor outcomes after lesion resection or hemispherectomy before VNS implantation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatrics, Peking University First Hospital, Beijing, China; Pediatric Epilepsy Center, Peking University First Hospital, Beijing, China.
- Pediatric Epilepsy Center, Peking University First Hospital, Beijing, China.
- Department of Pediatrics, Peking University First Hospital, Beijing, China; Pediatric Epilepsy Center, Peking University First Hospital, Beijing, China. Electronic address: dryewu@263.net.
Förderung
- National Key Research and Development Program of China
Zitieren
APA
Xie, H., Ma, J., Ji, T., Liu, Q., Cai, L., & Wu, Y. (2023). Efficacy of vagus nerve stimulation in 95 children of drug-resistant epilepsy with structural etiology. Epilepsy & Behavior. https://doi.org/10.1016/j.yebeh.2023.109107
Vancouver
Xie H, Ma J, Ji T, Liu Q, Cai L, Wu Y. Efficacy of vagus nerve stimulation in 95 children of drug-resistant epilepsy with structural etiology. Epilepsy & Behavior. 2023. doi:10.1016/j.yebeh.2023.109107
BibTeX
@article{Xie2023,
author = {Xie, Han and Ma, Jiayi and Ji, Taoyun and Liu, Qingzhu and Cai, Lixin and Wu, Ye},
title = {Efficacy of vagus nerve stimulation in 95 children of drug-resistant epilepsy with structural etiology},
journal = {Epilepsy & Behavior},
year = {2023},
doi = {10.1016/j.yebeh.2023.109107}
}
EUVIMED